Crescita Therapeutics Inc.
CRRTF
$0.2371
-$0.1155-32.76%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -50.02% | 87.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -50.02% | 87.11% | |||
| Cost of Revenue | -55.32% | 133.98% | |||
| Gross Profit | -43.10% | 48.35% | |||
| SG&A Expenses | -13.28% | -4.57% | |||
| Depreciation & Amortization | -5.64% | 13.94% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -36.31% | 43.99% | |||
| Operating Income | -634.86% | 88.28% | |||
| Income Before Tax | -416.63% | 83.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -461.28% | 84.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -461.28% | 84.77% | |||
| EBIT | -634.86% | 88.28% | |||
| EBITDA | -831.85% | 110.71% | |||
| EPS Basic | -459.02% | 84.52% | |||
| Normalized Basic EPS | -475.68% | 84.96% | |||
| EPS Diluted | -459.02% | 84.52% | |||
| Normalized Diluted EPS | -475.68% | 84.96% | |||
| Average Basic Shares Outstanding | -0.49% | -0.78% | |||
| Average Diluted Shares Outstanding | -0.49% | -0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||